A 12-week, Randomized, Double-masked, Parallel Group Comparison of Evening Dosing With Xalacom in Subjects With Glaucoma

PHASE3CompletedINTERVENTIONAL
Enrollment

528

Participants

Timeline

Start Date

December 31, 2005

Study Completion Date

June 30, 2007

Conditions
Open Angle GlaucomaOcular Hypertension
Interventions
DRUG

Xalacom

DRUG

Xalatan

DRUG

Timolol

Trial Locations (64)

11215

Pfizer Investigational Site, Brooklyn

14618

Pfizer Investigational Site, Rochester

19114

Pfizer Investigational Site, Philadelphia

19148

Pfizer Investigational Site, Philadelphia

19606

Pfizer Investigational Site, Reading

19610

Pfizer Investigational Site, Wyomissing

22405

Pfizer Investigational Site, Fredericksburg

27101

Pfizer Investigational Site, Winston-Salem

27710

Pfizer Investigational Site, Durham

29403

Pfizer Investigational Site, Charleston

29414

Pfizer Investigational Site, Charleston

32405

Pfizer Investigational Site, Panama City

32605

Pfizer Investigational Site, Gainesville

33136

Pfizer Investigational Site, Miami

34461

Pfizer Investigational Site, Lecanto

35216

Pfizer Investigational Site, Birmingham

37803

Pfizer Investigational Site, Maryville

40217

Pfizer Investigational Site, Louisville

47150

Pfizer Investigational Site, New Albany

47250

Pfizer Investigational Site, Madison

47630

Pfizer Investigational Site, Newburgh

47713

Pfizer Investigational Site, Evansville

48105

Pfizer Investigational Site, Ann Arbor

52245

Pfizer Investigational Site, Iowa City

55082

Pfizer Investigational Site, Stillwater

60409

Pfizer Investigational Site, Calumet City

60611

Pfizer Investigational Site, Chicago

60617

Pfizer Investigational Site, Chicago

60914

Pfizer Investigational Site, Bourbonnais

63090

Pfizer Investigational Site, Washington

64093

Pfizer Investigational Site, Warrensburg

64114

Pfizer Investigational Site, Kansas City

67208

Pfizer Investigational Site, Wichita

77055

Pfizer Investigational Site, Houston

78205

Pfizer Investigational Site, San Antonio

78209

Pfizer Investigational Site, San Antonio

78240

Pfizer Investigational Site, San Antonio

78705

Pfizer Investigational Site, Austin

78746

Pfizer Investigational Site, Austin

79902

Pfizer Investigational Site, El Paso

79904

Pfizer Investigational Site, El Paso

80907

Pfizer Investigational Site, Colorado Springs

83404

Pfizer Investigational Site, Idaho Falls

86001

Pfizer Investigational Site, Flagstaff

90048

Pfizer Investigational Site, Los Angeles

90701

Pfizer Investigational Site, Artesia

92663

Pfizer Investigational Site, Newport Beach

94105

Pfizer Investigational Site, San Francisco

95815

Pfizer Investigational Site, Sacramento

97470

Pfizer Investigational Site, Roseburg

98133

Pfizer Investigational Site, Seattle

04401

Pfizer Investigational Site, Bangor

01867

Pfizer Investigational Site, Reading

48201-1423

Pfizer Investigational Site, Detroit

63141-6846

Pfizer Investigational Site, Creve Coeur

08854-4143

Pfizer Investigational Site, Piscataway

08540-3211

Pfizer Investigational Site, Princeton

10032-3701

Pfizer Investigational Site, New York

27704-2122

Pfizer Investigational Site, Durham

27408-7022

Pfizer Investigational Site, Greensboro

44115-3176

Pfizer Investigational Site, Cleveland

75231-5185

Pfizer Investigational Site, Dallas

76102-4427

Pfizer Investigational Site, Fort Worth

77025-1635

Pfizer Investigational Site, Houston

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT00277498 - A 12-week, Randomized, Double-masked, Parallel Group Comparison of Evening Dosing With Xalacom in Subjects With Glaucoma | Biotech Hunter | Biotech Hunter